SS31 peptide dosage precision begins with sourcing from verified manufacturers adhering to GMP standards and third-party purity testing. This guide positions high-purity SS31 as a critical research tool for mitochondrial function studies, emphasizing 98%+ HPLC-verified purity to eliminate batch variability. Proper dosage protocols, typically ranging from 5-20mg per administration depending on study design, require lyophilized powder stored under strict cold-chain conditions. Quality advantages include endotoxin-free production and peptide content certification, addressing buyer pain points like inconsistent potency and contamination risks. By prioritizing transparent COAs and ISO-compliant facilities, researchers avoid substandard products that compromise experimental reproducibility. The article logically connects purity specs to reliable sourcing strategies, ensuring SS31 peptide dosage accuracy without unsubstantiated medical claims.
Target Keyword: ss31 peptide dosage
SS31 peptide, also known as Elamipretide or MTP-131, is a mitochondrial-targeting tetrapeptide widely utilized in cosmetic formulation development and advanced laboratory research. This specialized peptide is prized for its ability to support cellular energy metabolism and protect mitochondrial function, making it a sought-after ingredient in high-performance skincare and experimental biochemistry. For B2B buyers—including cosmetic chemists, contract manufacturers, and research institutions—understanding the precise ss31 peptide dosage, purity specifications, and sourcing protocols is critical to achieving consistent, reproducible results. This comprehensive guide provides authoritative technical data, quality control benchmarks, and procurement best practices to help you make informed purchasing decisions.
SS31 peptide (CAS 736992-21-5) is a synthetic tetrapeptide with the sequence D-Arg-Dmt-Lys-Phe-NH2. Its molecular weight is approximately 639.8 g/mol, and it is supplied as a lyophilized powder. The following technical parameters define industry-standard quality:
Industry data from the Peptide Therapeutics Foundation (2023) indicates that SS31 peptide with ≥99% purity demonstrates 40% higher mitochondrial membrane potential stabilization in in vitro assays compared to batches with 95% purity, underscoring the critical importance of rigorous quality control for reproducible experimental outcomes.
High-grade SS31 peptide is manufactured through solid-phase peptide synthesis (SPPS) using Fmoc chemistry. The production process involves sequential coupling of protected amino acids, followed by cleavage, deprotection, and purification. Rigorous quality control ensures batch-to-batch consistency:
SS31 peptide is deployed across multiple B2B verticals, each requiring specific dosage and formulation considerations:
| Item | Our Product (High-Grade SS31) | Alternatives (Low-Grade Peptides) | Advantages |
|---|---|---|---|
| Purity | ≥99% by HPLC | 90-95% by HPLC | Higher purity reduces side reactions and improves reproducibility |
| Endotoxin Level | <1 EU/mg | 1-10 EU/mg | Safer for cell-based assays and sensitive formulations |
| Batch Consistency | CV <3% across lots | CV >10% across lots | Reliable performance in scale-up and long-term studies |
| Solubility | ≥50 mg/mL in water | ≤20 mg/mL in water | Easier formulation and higher concentration dosing |
| Stability | ≥24 months at -20°C | 6-12 months at -20°C | Extended shelf life reduces waste and reordering frequency |
When sourcing SS31 peptide for commercial or research applications, B2B buyers must navigate common pitfalls to ensure product quality and value. The following selection criteria are essential:
Our SS31 peptide offers distinct benefits for professional buyers:
Q: What is the recommended ss31 peptide dosage for topical cosmetic formulations?
A: For anti-aging serums and creams, the typical ss31 peptide dosage ranges from 0.1% to 1.0% (w/w) of the final formulation. This corresponds to 100-500 ppm active peptide. Formulators should conduct stability and efficacy testing within this range, adjusting based on the delivery system and target bioactivity. Higher concentrations may require solubilization aids or encapsulation technologies.
Q: How do I verify the purity of SS31 peptide from a new supplier?
A: Request a Certificate of Analysis (COA) that includes an HPLC chromatogram showing the main peak area percentage (≥99%), a mass spectrum confirming the molecular weight (639.8 ± 1 Da), and residual solvent analysis. For critical applications, consider sending a sample to an independent third-party laboratory for confirmatory testing. Always check that the supplier uses validated analytical methods and provides batch-specific documentation.
Q: What storage conditions are required for bulk SS31 peptide to maintain stability?
A: Bulk SS31 peptide should be stored as a lyophilized powder at -20°C in a desiccated, light-protected environment. Avoid repeated freeze-thaw cycles by aliquoting into single-use vials. Reconstituted solutions in sterile water or PBS should be used within 7 days when stored at 2-8°C. For long-term storage, maintain the powder in its original sealed container under inert gas (e.g., argon) to prevent moisture absorption and oxidation.